Stathmin1 (STMN1) is a microtubule modulator that is expressed in multiple cancers and
correlates with poor survival. We previously demonstrated in vivo safety of bifunctional (bi) …

Stathmin-1 (STMN1) is a microtubule-destabilizing protein which is overexpressed in
cancer. Its overexpression is associated with poor prognosis and also serves as a predictive …

Bifunctional small hairpin RNAs (bi-shRNAs) are functional miRNA/siRNA composites that
are optimized for posttranscriptional gene silencing through concurrent mRNA cleavage …

Stathmin (STMN1) regulates microtubule dynamics by promoting depolymerization of
microtubules and/or preventing polymerization of tubulin heterodimers. Several studies have …

Stathmin (STMN) plays a vital role in maintaining the malignant behavior of cancer through
directly regulating microtubule dynamics equilibrium. Taxol, an effective chemotherapeutics …

RNA interference (RNAi) is a natural cellular regulatory process that inhibits gene
expression by transcriptional, post-transcriptional and translational mechanisms. Synthetic …

Abstract Background and Aim We have reported previously that RNA interference targeting
stathmin1 (STMN1) gene in human gastric cancer cells inhibits proliferation in vitro and …

Stathmin 1 (STMN1), also known as p17, p18, p19, 19K, metablastin, oncoprotein 18, LAP
18 and Op18, is a 19 kDa cytosolic protein. It was the first discovered member of a family of …

Background To investigate the mechanism of action of stathmin1 (STMN1) in mesothelioma
(MSM) and whether it has any role in its treatment. Methods STMN1 expression was …

Full article: Stathmin 1: a protein with many tasks. New biomarker and potential target in
cancer Skip to Main Content Taylor and Francis Online homepage Taylor and Francis Online …